EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

m6A deficiency induces dopaminergic neurodegeneration and progressive parkinsonism through a pathogenic loop with mitochondria

Sun Liu, Qihuan Ren, Guiling Mo, Zengguang Li, Huili Huang, Yuhao Zhou, Ziteng Miao, Xin Cao, Bilian Wu, Zhuoyu Xiao, Shihui Yu, Guangjin Wu und 7 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci197183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Sun Liu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Mitochondria, Dopaminergic Neurons, Parkinsonian Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite substantial progress in understanding the molecular pathology of Parkinson’s disease (PD), the underlying drivers of PD in many cases remain unknown. Here, we investigate the role of RNA modification in PD, following observations of selective m 6 A hypomethylation in the substantia nigra (SN) of mouse PD models and dysregulated METTL3 and ALKBH5 expression in dopaminergic (DA) neurons from patients with PD. We found preferential m 6 A deposition on transcripts of PD risk genes and what we believe to be a previously unreported heterozygous METTL3 p.K480R mutation in patients with PD. Mettl3 K480R/+ mice exhibited progressive METTL3 reduction and m 6 A hypomethylation in the SN, leading to progressive DA neuron loss, phospho-α-synuclein increase, and levodopa-responsive motor and nonmotor deficits, mimicking PD progression. Dopamine transporter–specific METTL3 knockout mice recapitulate m 6 A hypomethylation, neurodegeneration, and levodopa-responsive parkinsonism. Mechanistically, m 6 A deficiency disrupted mitochondrial biogenesis and function through regulating Tfam expression, while mitochondrial dysfunction reciprocally impaired m 6 A deposition, creating a pathogenic loop. Importantly, supplementation with S-adenosylmethionine (SAMe) enhanced m 6 A modification, disrupted the pathogenic loop, and alleviated parkinsonism in mouse models. Our findings revealed m 6 A dysregulation as an important contributor to PD pathogenesis, provide a valuable preclinical mouse model for PD progression, and highlight RNA methylation-targeted therapies as a promising strategy for PD intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaDopaminergic NeuronsParkinsonian DisordersAnimalsMiceRNA MethylationHumansMethyltransferasesMice, KnockoutSubstantia NigraEpitranscriptomeMaleDNA-Binding ProteinsTranscription FactorsDisease Models, AnimalMitochondrial ProteinsHigh Mobility Group Proteins

Stichwörter der Autor:innen

GeneticsMitochondriaNeuroscienceParkinson diseaseRNA processing

Substanzen

MethyltransferasesMettl3 protein, mouseTfam protein, mouseDNA-Binding ProteinsTranscription FactorsMitochondrial ProteinsHigh Mobility Group Proteins

Autor:innen und Institutionen

  • Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • Guangzhou KingMed Diagnostics Group Co. Ltd., International Biotech Island, Guangzhou, China.
  • State Key Laboratory of Multi-organ Injury Prevention and Treatment, Southern Medical University, Guangzhou, China.
  • Key Laboratory of Mental Health of the Ministry of Education, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
  • School of Bioscience and Biopharmaceutics, Guangdong Province Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou, China.

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Liu, S., Ren, Q., Mo, G., Li, Z., Huang, H., Zhou, Y., Miao, Z., Cao, X., Wu, B., Xiao, Z., Yu, S., Wu, G., Xia, L., Cui, J., Mo, J., Li, Y., Xia, L., Shen, J., & Xiao, S. (2026). m6A deficiency induces dopaminergic neurodegeneration and progressive parkinsonism through a pathogenic loop with mitochondria. Journal of Clinical Investigation. https://doi.org/10.1172/jci197183

Vancouver

Liu S, Ren Q, Mo G, Li Z, Huang H, Zhou Y, et al. m6A deficiency induces dopaminergic neurodegeneration and progressive parkinsonism through a pathogenic loop with mitochondria. Journal of Clinical Investigation. 2026. doi:10.1172/jci197183

BibTeX
@article{Liu2026,
  author = {Liu, Sun and Ren, Qihuan and Mo, Guiling and Li, Zengguang and Huang, Huili and Zhou, Yuhao and Miao, Ziteng and Cao, Xin and Wu, Bilian and Xiao, Zhuoyu and Yu, Shihui and Wu, Guangjin and Xia, Linjian and Cui, Jinru and Mo, Junyuan and Li, Yuan and Xia, Laixin and Shen, Juan and Xiao, Shan},
  title = {m6A deficiency induces dopaminergic neurodegeneration and progressive parkinsonism through a pathogenic loop with mitochondria},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci197183}
}
Kostenlos starten →